Medical Management
Resume:
Michael N. Weisburgh, PharmD, BCPS, BCPP
Chesapeake Beach, MD 20732
Home – 410-***-****
Cell – 443-***-****
E-mail – **********@*******.***
**********@*****.***
NPI Number - 152*******
Education
1997-2001 Shenandoah University, Winchester, VA
Doctor of Pharmacy Graduated: May 12, 2001
1993-1997 University at Buffalo, Buffalo, NY
Majored in Chemistry with a minor in Biochemical Pharmacology
License Status
o Licensed Pharmacist in Maryland – 16582
Licensed to Administer Vaccinations
Employment History
November 2012 – March 2013
• Community Pharmacist
• K-Mart (Sears Holding Company)
• 685 Solomons Island Road
• Prince Frederick MD 20678
April 2009 – October 2012
• Clinical Community Pharmacist
• Giant of Landover
• 655 Solomons Island Road
• Prince Frederick MD 20678
August 2003 – March 2009
• Clinical Pharmacist
• Calvert Memorial Hospital
• 100 Hospital Road
• Prince Frederick MD 20678
May 2001 – May 2004
• Per Diem Pharmacist
• CVS Pharmacy
• 1 CVS Drive
• Woonsocket, RI
July 2002 – August 2003
• Critical Care Pharmacist
• Weinberg (Surgical) Intensive Care Unit
• The Johns Hopkins Hospital
• 640 North Wolfe Street
• Baltimore, MD 21287
July 2001 – June 2002
• Pharmacy Practice Resident – ASHP Certified
• Beth Israel Deaconess Medical Center
• Affiliated with Harvard Medical School
• 1 Deaconess Road
• Boston, MA 02215
Faculty Appointments and Lectures
Adjunct Instructor in Clinical Pharmacy (2001-2002)
Massachusetts College of Pharmacy and Health Sciences
179 Longwood Ave
Boston, MA 02215
Clinical Assistant Professor (2002 – Present)
University of Maryland School of Pharmacy
Baltimore, MD
Shenandoah University School of Pharmacy
Guest Lecturer – April 21, 2014
ADHD Therapeutics – 3rd Year Pharmacy Students
Responsibilities at K-Mart and Giant Pharmacy
• Medication Therapy Management (MTM) via the Get Outcomes Program
• Review and dispense all prescriber orders
• Patient counseling on all relevant prescriptions
• Precepting 4th year Maryland School of Pharmacy Students
• Give vaccinations to appropriate patients
• Manage weekly inventory, ordering, CII, and budget reports
Responsibilities at Giant Pharmacy
• Developed a program while patients received their influenza vaccinations to
screen for Pneumovax and Zostavax eligibility
• Developed store based MTM program for pharmacists to communicate with local
prescribers and aid in patient care
• Worked with Carol Porto Treatment Center in aiding substance abuse patients
• Worked with Calvert County Hospice in aiding end of life care and comfort
• Registered Clozaril Pharmacist, monitor all aspects of pharmaceutical care for
private patients and patients of Calvert County Health Department
Responsibilities at Calvert Memorial Hospital
Responsible for all Pharmacy consults, which include but were not limited to:
• TPN/Nutrition – Assessing nutritional status of patients and ordering of all
parenteral nutrition along with necessary electrolytes and medications (i.e.
famotidine, metoclopramide, etc.)
• Pain Management – Responsible for assessing, ordering, and monitoring all post
op PCA orders and pain medications for surgical patients. As well as pain
management consults from providers. This entailed assessing a patient’s
requirements and ordering all necessary medications (narcotics, NSAIDS, anxiety
medication, anti-psychotics, nausea/vomiting medications).
• Vancomycin and Aminoglycoside Consults – Manage all Vancomycin and
aminoglycoside (gentamicin, tobramycin, and amikacin) orders for providers.
This entailed pharmacokinetic dosing, ordering of levels, monitoring of side
effects and other appropriate measures.
• Warfarin Management – Ordering, monitoring and adjustment of warfarin therapy
for patients.
• Sedation/Anxiety/Paralytic Management – Monitoring and adjustment of all
sedative drips for ICU patients. This included but not limited to benzodiazepines,
narcotics, and paralytics.
• Electrolyte Management – Monitor and order as needed electrolytes for patients.
This included patients with elevated and low electrolyte levels such as potassium
and calcium.
• Xigris ® Consults – Review ALL patients with documented sepsis for possible
Xigris ® use and discuss with intensivist and infectious disease providers.
• Responsible for IV to PO conversions, Therapeutic drug monitoring, and MAR
reviews.
• Medication reconciliation performed for all patients admitted with their outpatient
pharmacies and providers.
• End of life care – responsible for ordering and adjust appropriate medications to
make patient and family as comfortable as possible.
• Responsible for various other educational and community functions (i.e. health
fairs, brown bags at nursing homes, etc.).
• Precept University of Maryland School of Pharmacy 4th year students.
• Order entry and review all medication orders for patients.
• Monitoring of ADR and medication errors throughout the hospital.
• Developed several order sets for inpatients based on evidence-based guidelines,
hospital formulary, and cost analysis reports.
• On-call clinical pharmacist for all health care providers.
Anticoagulation Clinic Outpatient Pharmacist
• Responsible for monitoring INR levels and adjusting warfarin dose.
• Responsible for adjusting other prescription, OTC and supplement dosing (with
provider) in response to INR level.
• Responsible for ordering vitamin K if INR level warranted this.
• Responsible for “bridging” therapy for patients transitioning over to warfarin
from parenteral product.
Clinical Pharmacist for Behavioral Health Unit (psychiatric unit)
• Participate in daily interdisciplinary rounds
• Participate in patient daily goals group
• Participate and supervise patient medication groups
• Responsible for quarterly in-service for nursing, social workers, mental health
counselors, nurse practitioners and physicians
• Regularly met with patients one-on-one to discuss therapeutic goals and way to
achieve them
• Responsible for ICU patient assessments for the management of ICU psychosis.
• Semi annual behavioral health MUE on anti depressants in adolescents.
• Developed Level 5 admission order sets for adults and adolescents (inpatient and
outpatient)
Committee Memberships
• Member of Medication Safety and Usage Team (MUST) or Pharmacy and
Therapeutics Committee
• Hospital Nutritional Committee
• Hospital Ethics Committee
• Member of Stroke Team
• Behavioral Health Leadership Team
• Medication Reconciliation Team
Responsibilities at The Johns Hopkins Hospital
• Precept Pharmacy Practice Residents and 4th year pharmacy students in the care of
critically ill patients as well as general surgery patients.
• Attend and participate in daily patient care rounds, which included but was not
limited to:
a. Recommended appropriate medications based on diagnosis.
b. Pharmacokinetic and renal dosing for all relevant medications
(Vancomycin, aminoglycosides, amphotericin, etc.)
c. Xigris ® consults and approvals for appropriate patients.
d. Evidence based recommendations in the care of post op and critically
ill patients.
e. Dosing of all sedative drips, paralytic drips, and vasopressor drips.
f. Transitioned patients to oral medications when appropriate.
• Assessed patients for ICU related psychosis and recommended potential treatment
and monitoring
• Developed oral iron replacement protocol for post op patients.
• Developed stress ulcer prophylaxis protocol for post op patients.
• Taught pharmacy, nursing and medical residents and students on the
pharmaceutical care needs of post op patients.
• Assessed status post surgery patients, entered and verified post op orders and
recommended changes if needed.
• Sat on Surgical Intensive Care Unit (SICU) process improvement (PI) committee
• Sat on SICU PI sub committee developing a weight based heparin protocol for use
in the SICU.
• Sat on SICU PI sub committee developing an intravenous insulin protocol for
patients in the SICU
• Co-chair The Weinberg Surgical Pharmacy/Nursing Committee
• Responsible for monthly in-services to all health care providers in the WICU
• Responsible for as needed in-services to PACU (post anesthesia care unit) nurses.
Clinical Rotations Completed at BIDMC/MCP
• July 23 – August 31, 2001 – Internal Medicine – Margarita Desyatnik, PharmD,
BCPS
• September 4 – October 12, 2001 – Cardiac Care Unit – Toby Trujillo, PharmD,
BCPS
• October 15 – November 16, 2001 – Cardiac Surgery Recovery Unit – Thomas
Guerriero, PharmD
• November 19 – December 21, 2001 – Medical Intensive Care Unit – Lisa
Saubermann, PharmD
• January 7 – February 1, 2002 – Surgical Intensive Care Unit – Thomas
Guerriero, PharmD
• February 4 - March 1, 2001 – Nephrology – Susan Krikorian, MS, RPh
• April 8 – Mary 3, 2002 – Medical Intensive Care Unit- Lisa Saubermann,
PharmD
• May 6 – May 31, 2002 – Infectious Disease – Chris McCoy, PharmD
Projects and Responsibilities at BIDMC
• Participate in and take minutes for all Pharmacy and Therapeutic meetings
• Sit on Institutional Review Board (IRB)
o Developed a cost analysis report of studies in which medication was going
to be used.
o This report was subsequently presented at P&T meetings
• Developed a drug use evaluation (DUE) on Precedex ® (dexmedetomidine)
o Presented at January 2002 P&T meeting
• Presented one hour CE on Geriatric Pharmacotherapy to pharmacists
o Presented in March 2002
• Staffing responsibilities were one day a week and one weekend a month
• Drug information responsibilities included sending out a question of the week to
pharmacists, answering questions from clinical pharmacy beeper
• Developed and published a Department of Pharmacy newsletter called
“Pharmacy Times”
Educational Activities at MCP
• Aid primary preceptor with Pharmacy students on clinical rotations. Students
were on clinical rotations at BIDMC throughout the year.
• Precept two pharmacy students for four weeks a piece on their clinical rotations
• Taught therapeutics seminar to final academic school year pharmacy students
during second academic semester
• Lectured on “Advanced Thyroid Therapeutics” to final academic year pharmacy
students on November 29 and 30, 2001.
• Lectured to Physician Assistant students “Thyroid Therapeutics” on January 29,
2002.
Professional Publications and Presentations
Dr. Troy Wood, Sajid Bashir, Michael Cieslar, Gisela Cymes, Craig Dufrense, Sarah
Lorenz, Peter Maziarz, Henry Padley, Chris Remsen, and Michael N Weisburgh. From
Nanospray to Macromolecules: The Undiscovered Country of Electrospray Fourier Mass
Spectrometry. Presented at the 24thAnnual Federation of Analytical Chemistry a
Spectroscopy Societies, Providence, RI October 26-30, 1997
Drs. Michael N Weisburgh and Lisa Saubermann. Development of an Adverse Drug
Reaction Surveillance, Detection and Educational Program. Presented at the 21 Annual
Eastern States Conference for Pharmacy Residents and Preceptors, Baltimore, MD April
2002.
Drs. Michael N. Weisburgh and Lisa Saubermann. Development of an Adverse Drug
Reaction Surveillance Detection and Educational Program. Poster Presented at 37th
Annual ASHP Clinical Mid year meeting, Atlanta, GA, December 8-12, 2002
Drs. Michael N. Weisburgh, Vince Jackson, Kara Harrer, Melissa Wanner, Donna
Deninno, Ms. Sharon Baker & Dorothie Briggs. Pharmacist Controlled Post-Operative
PCA Management. Poster Presented at ASHP midyear 2007.
Research
February 1997 – May 1997 University at Buffalo, Buffalo, NY
Analysis of Macromolecules (Taxol, Oligonucleotides, Proteins, & PALA) using Fourier
Transform Mass Spectrometry.
Research work done under: Troy Wood, PhD, Associate Professor of Chemistry,
University at Buffalo.
August 2000 – December 2000 Shenandoah University, Winchester, VA
Survey of healthcare professionals on the use of PDA’s and similar devices in healthcare
settings. Research to see if these devices had a direct impact on patient care.
Research work done under: Richard Stull, PhD, Associate Dead and Professor of
Pharmacology at Bernard J Dunn School of Pharmacy.
October 2001 – April 2002 Beth Israel Deaconess Medical Center, Boston, MA
Development of an adverse drug reaction surveillance, detection and educational
program
Research work done in collaboration with: Lisa Suabermann, PharmD Manager
QA/Process Improvement at Beth Israel Deaconess Medical Center
January 2002 – June 2002 Beth Israel Deaconess Medical Center, Boston, MA
Partnering with Patients for Medication Safety Study. The goal of this study was to
determine whether more or less information given to patients had an impact on adverse
drug reactions.
Research work done under: Saul Weingart, MD - Principal Investigator.
Technology Skills
• Windows XP, Vista, 7, 8, Mac OS X, Blackberry, Windows Phone, Android OS,
and IOS
• Zadol, BDM, Meditech, PDX, and CVS Rx 2000
Certifications
• BLS (Basic Life Support) 2002 – Present
• ACLS (Advanced Cardiac Life Support) 2005-2009
• Board Certified Pharmacotherapy Specialist 2005 – Present
• Board Certifies Psychiatric Pharmacist 2007 – Present
• Get Outcomes Certified (MD16582) 2009 – Present
Awards Received
• GlaxoSmithKline Pharmaceutical Award for Superior Achievement in Patient
Care (2001)
• Parks Foundation to Excellence Pharmacy Scholarship (2000)
• Certificate of Merit Calvert Memorial Hospital
o Developing and implementing a medication barcode system for entire
hospital 2009
References
Brendon McQuighan, PharmD
**********@*****.***
*******.*********@*********.***
Margaret Eller, RN
***********@*******.***
********.*****@*******.***
Marijo Cosmas, NP
**.**********@*****.***
Contact this candidate